Inflammatory Disease | Australian Biotech Company News

Home Tags Inflammatory Disease

Biotechnology

€18M to Fund First-in-Class Systemic Sclerosis Drug

BioChannel - July 9, 2020

Biotechnology

Boost For Inflammatory Disease Biotech NodThera With €49M Series B

BioChannel - June 6, 2020

Biotechnology

Rare Inflammatory Disease Drug Beats Immunosuppressants in Phase III

BioChannel - November 26, 2019

Biotechnology

Update: Abivax’s Ulcerative Colitis Drug Effective Long-Term

BioChannel - October 21, 2019

Biotechnology

French Biotech to Develop Septic Shock Therapy with €39M Series B

BioChannel - September 12, 2019

Biotechnology

This Biotech Uses Messenger RNA to Treat Lethal Lung Inflammation

BioChannel - August 2, 2019

Biotechnology

Dutch Antibodies for Autoimmune Diseases Boosted by €15M Series A

BioChannel - July 4, 2019

Biotechnology

Shares Drop 90% as Antibody for Inflammatory Skin Disease Fails Phase...

BioChannel - June 6, 2019

Stay connected

Recent posts

Life in the Time of Coronavirus

BioChannel - July 10, 2020

Study pinpoints brain cells that trigger sugar cravings and consumption

BioChannel - July 10, 2020

Life Sciences Fund Launches with €76M to Invest in Nordic Biotech

BioChannel - July 10, 2020

Random article

Life in the Time of Coronavirus

Study pinpoints brain cells that trigger sugar cravings and consumption

Life Sciences Fund Launches with €76M to Invest in Nordic Biotech

VarmX bags €32m in Series B round – European Biotechnology News